Los Angeles, CA, USA, ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it has signed a new multi-year, non-exclusive supply agreement with Genmab A/S, an international biotechnology company. Under
More
By N. Krishnamurthy, CEO at VSM Software Pvt. Ltd. It all started
Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products
HONG KONG, Sisram Medical Ltd (the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred as the “Group”), a
MoreSterling Pharma Solutions, a global contract development and manufacturing organisation, today announced that it had reached agreement with Novartis to
MoreMONTGOMERY, Ala. and PRINCETON, N.J. and LONDON and BANGALORE, India, Aedesius Health, a division of AedesiusOne Ltd, and its biopharmaceutical
MoreCambridge, UK, Framingham, MA (USA), and Dijon, France, Abzena, a partner research organization for integrated services from discovery through to clinical
MoreHoboken, NJ, Rostock/Berlin, Germany, Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well
More
NOTTINGHAM (UK) Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the
More
HONG KONG, Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the
MoreDean Kavanagh, Managing Director of QED Environmental Systems Ltd in the UK, has been appointed Co-Chair of the Council of
MoreRockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced
MoreGlobal contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in
More
